Doctor profile · Federal record
Dr. JAMES BROUSSARD, MD
Otolaryngology Physician (CMS: OTOLARYNGOLOGY) · THIBODAUX, LA
- NPI 1760581706
- Accepts Medicare
- MIPS 90.1 / 100 · 2023
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
604 N. ACADIA RD STE 101
THIBODAUX, LA 703014897
(985) 446-5079
fax (985) 447-2497 - Mailing address
-
604 NORTH ACADIA STE 101
THIBODAUX, LA 703014897
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- March 28, 2024
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207Y00000X — NUCC code
- State license (1)
- Louisiana #018177
- Medicaid
- LA #1370258
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760581706. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,891
Distinct HCPCS
10
Medicare allowed
$87,759
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
86003 |
Measurement of antibody (ige) to allergic substance, crude allergen extract, each | 805 | 16 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 205 | 143 | $84 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 161 | 105 | $119 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 79 | 72 | $52 | |
92567 |
Test to assess middle ear function | 74 | 71 | $15 | |
92557 |
Comprehensive hearing and speech recognition test | 69 | 69 | $35 | |
31575 |
Diagnostic exam of voice box using a flexible endoscope | 61 | 44 | $119 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 61 | 61 | $106 | |
69210 |
Removal of impacted ear wax | 55 | 52 | $42 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 50 | 21 | $7 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 102. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$456
Transactions
16
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Acclarent, Inc | 2 | $175.06 | |
| GlaxoSmithKline, LLC. | 4 | $79.48 | |
| GENZYME CORPORATION | 3 | $52.38 | |
| AERIN MEDICAL INC. | 2 | $46.09 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $39.00 | |
| Integra LifeSciences Corporation | 1 | $32.80 | |
| Pacira Pharmaceuticals Incorporated | 1 | $17.69 | |
| AstraZeneca Pharmaceuticals LP | 1 | $13.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
663
Patients
206
Total drug cost
$52,066
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluticasone Propionate | Generic | 163 | 60 | $2,843 |
| Omeprazole | Generic | 115 | 26 | $1,366 |
| Famotidine | Generic | 67 | 14 | $703 |
| Montelukast Sodium | Generic | 52 | 12 | $778 |
| Azelastine Hcl | Generic | 49 | 25 | $1,476 |
| Triamterene-Hydrochlorothiazid (Triamterene/Hydrochlorothiazid) | Brand | 42 | 15 | $411 |
| Levothyroxine Sodium | Generic | 41 | 0 | $437 |
| Xhance (Fluticasone Propionate) | Brand | 21 | 0 | $17,783 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 20 | 0 | $14,450 |
| Cefdinir | Generic | 17 | 14 | $370 |